Cargando…
Fluorouracil/oxaliplatin/panitumumab: Lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163862/ http://dx.doi.org/10.1007/s40278-022-16542-7 |
Ejemplares similares
-
Cardiac metastasis from colon cancer effectively treated with 5-fluorouracil, leucovorin, and oxaliplatin (modified FOLFOX6) plus panitumumab: a case report
por: Tsujii, Yoshiki, et al.
Publicado: (2017) -
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO
por: Rossini, Daniele, et al.
Publicado: (2022) -
Fluorouracil/oxaliplatin: Coronary vasospasm and neutropenia: case report
Publicado: (2019) -
Fluorouracil/folinic acid/oxaliplatin: Various toxicities: 2 case reports
Publicado: (2021) -
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report
por: Takahashi, Makoto, et al.
Publicado: (2014)